Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Remedy Drinks Completes Series B Funding

2023-02-21
LOS ANGELES, CA, Remedy Drinks announces the closing of a Series B funding round from its existing lead investors L Catterton and Kin Group.
Remedy Drinks, the innovator of shelf-stable, no-sugar, better-for-you beverages, announces the closing of a Series B funding round from its existing lead investors L Catterton and Kin Group. The new capital raised will be focused on global retail growth through new distribution and retail takeaway. Remedy Drinks also announces the appointment of a new Chief Customer Officer, Nathan Schy. As the third largest kombucha brand globally and fastest growing in the U.S. market (272% year-over-year via SPINS), Schy will aggressively build on this momentum with existing and new customers.

Remedy Drinks was launched in 2012 by fermentation fanatics Sarah and Emmet Condon in their Melbourne, Australia kitchen. With the vision to make healthy beverages tasty and convenient, and just overall better, Remedy Drinks offers delicious and healthy no sugar, live-cultured drinks, full of organic acids, and antioxidants. No sugar means the company's raw and unpasteurized, strong cultures are able to stay live throughout shelf life, with no risk of fermentation, allowing them to be stable both in or out of the fridge.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors